HOME › Press Releases › Immunoassay Market worth $23.7 Billion by 2019
Immunoassay Market worth $23.7 Billion by 2019
The report "Immunoassay Market by Technology (ELISA, Fluorescence, Colorimetric, Chemiluminescence, Rapid Test, Western Blot, ELISPOT, PCR), Application (Infectious Disease, Endocrinology, Cardiology, Oncology, Hematology), & End User - Global Forecast to 2019", provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the immunoassay along with estimates and forecasts of the revenue and share analysis.
Browse 352 market data tables and 40 figures spread through 305 pages and in-depth TOC on “Immunoassay Market by Technology (ELISA, Fluorescence, Colorimetric, Chemiluminescence, Rapid Test, Western Blot, ELISPOT, PCR), Application (Infectious Disease, Endocrinology, Cardiology, Oncology, Hematology), & End User - Global Forecast to 2019"
Early buyers will receive 10% customization on reports.
The global immunoassay market is expected to reach $23,712.4 Million by 2019 from $14,926.3 Million in 2014, at a CAGR of 9.7% from 2014 to 2019.
The report segments the immunoassay market based on technology, products and services, technologies, applications, end users, and regions. Among the various products and services available, the reagents and kits segment accounted for the largest share of the immunoassay market in 2014. This segment is also expected to grow at the highest CAGR during the forecast period, owing to the increase in immunoassay tests conducted due to rising aging population, rising number of chronic diseases, increased variety of reagents and the analytical techniques employed, trends like the high-growth at-home testing market, and accessibility to a wide range of reagents.
Based on region, the global immunoassay market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). In 2014, North America accounted for the largest share of the market, while Asia is expected to witness the highest growth rate.
Key players in the immunoassay market include are Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), Abbott Laboratories (U.S.), Beckman Coulter (U.S.), Ortho Clinical Diagnostics (U.S.), and bioMérieux (France).
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252